Literature DB >> 22461142

Genetics of pediatric renal tumors.

Brigitte Royer-Pokora1.   

Abstract

Wilms tumor (WT) accounts for approximately 95 % of all pediatric renal tumors, with a peak incidence between 2 and 3 years of age. It occurs in sporadic and congenital forms, the latter often occurring before 1 year of age. Incidence declines with age, and WT rarely is observed in adults. WT is an embryonal tumor of the kidney caused by aberrant proliferation of early metanephric kidney cells. It can arise from more than one developmental error and therefore several subtypes can be defined. WT1, a zinc-finger transcription factor, was identified as the first WT gene. Other genes frequently altered somatically in subsets of WT are CTNNB1 and WTX; both genes influence the Wnt signalling pathway. Imprinting alterations of genes in 11p15 are also observed in a subset of WTs. Other pediatric renal tumors occur less often, e.g. malignant rhabdoid tumor of the kidney, clear-cell sarcoma, desmoplastic small-round-cell tumors, congenital mesoblastic nephroma, renal cell carcinoma of childhood, renal primitive neuroectodermal tumors, renal medullary carcinoma, and synovial sarcoma of the kidney. In most of these, characteristic genetic alterations have been identified that help in the unequivocal diagnosis of these childhood renal cancers that are often difficult to distinguish.

Entities:  

Mesh:

Year:  2012        PMID: 22461142     DOI: 10.1007/s00467-012-2146-4

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  54 in total

1.  Fanconi anemia is associated with a defect in the BRCA2 partner PALB2.

Authors:  Bing Xia; Josephine C Dorsman; Najim Ameziane; Yne de Vries; Martin A Rooimans; Qing Sheng; Gerard Pals; Abdellatif Errami; Eliane Gluckman; Julian Llera; Weidong Wang; David M Livingston; Hans Joenje; Johan P de Winter
Journal:  Nat Genet       Date:  2006-12-31       Impact factor: 38.330

2.  A nucleolar protein, H19 opposite tumor suppressor (HOTS), is a tumor growth inhibitor encoded by a human imprinted H19 antisense transcript.

Authors:  Patrick Onyango; Andrew P Feinberg
Journal:  Proc Natl Acad Sci U S A       Date:  2011-09-21       Impact factor: 11.205

3.  WT-1 is required for early kidney development.

Authors:  J A Kreidberg; H Sariola; J M Loring; M Maeda; J Pelletier; D Housman; R Jaenisch
Journal:  Cell       Date:  1993-08-27       Impact factor: 41.582

4.  Wilms tumor in a patient with 22q11.2 microdeletion.

Authors:  Paul T Finch; Eniko K Pivnick; Wayne Furman; Christine C Odom
Journal:  Am J Med Genet A       Date:  2011-03-31       Impact factor: 2.802

Review 5.  Surveillance for Wilms tumour in at-risk children: pragmatic recommendations for best practice.

Authors:  R H Scott; L Walker; Ø E Olsen; G Levitt; I Kenney; E Maher; C M Owens; K Pritchard-Jones; A Craft; N Rahman
Journal:  Arch Dis Child       Date:  2006-07-20       Impact factor: 3.791

6.  Software and database for the analysis of mutations in the human WT1 gene.

Authors:  C Jeanpierre; C Béroud; P Niaudet; C Junien
Journal:  Nucleic Acids Res       Date:  1998-01-01       Impact factor: 16.971

7.  Mutation and cancer: statistical study of retinoblastoma.

Authors:  A G Knudson
Journal:  Proc Natl Acad Sci U S A       Date:  1971-04       Impact factor: 11.205

8.  Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer.

Authors:  I Versteege; N Sévenet; J Lange; M F Rousseau-Merck; P Ambros; R Handgretinger; A Aurias; O Delattre
Journal:  Nature       Date:  1998-07-09       Impact factor: 49.962

9.  PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene.

Authors:  Nazneen Rahman; Sheila Seal; Deborah Thompson; Patrick Kelly; Anthony Renwick; Anna Elliott; Sarah Reid; Katarina Spanova; Rita Barfoot; Tasnim Chagtai; Hiran Jayatilake; Lesley McGuffog; Sandra Hanks; D Gareth Evans; Diana Eccles; Douglas F Easton; Michael R Stratton
Journal:  Nat Genet       Date:  2006-12-31       Impact factor: 38.330

Review 10.  The many facets of the Wilms' tumour gene, WT1.

Authors:  Peter Hohenstein; Nicholas D Hastie
Journal:  Hum Mol Genet       Date:  2006-10-15       Impact factor: 6.150

View more
  12 in total

1.  High dose therapy for recurrent Wilms' tumor.

Authors:  Thomas W McLean
Journal:  Transl Pediatr       Date:  2014-01

2.  Clear cell sarcoma of the kidney in children: a clinopathologic analysis of three cases.

Authors:  Shaohua Chen; Ming Li; Ran Li; Jintao Cao; Qiong Wu; Ting Zhou; Zhaogen Cai; Nan Li
Journal:  Int J Clin Exp Pathol       Date:  2020-04-01

Review 3.  Malignant rhabdoid tumor of the small intestine in adults: a brief review of the literature and report of a case.

Authors:  Costantino Voglino; Maximilian Scheiterle; Giulio Di Mare; Federico Mariani; Alfonso De Stefano; Alessandro Ginori; Lorenzo De Franco; Francesco Ferrara
Journal:  Surg Today       Date:  2014-06-25       Impact factor: 2.549

4.  Clinical and molecular characterization of patients with heterozygous mutations in wilms tumor suppressor gene 1.

Authors:  Anja Lehnhardt; Claartje Karnatz; Thurid Ahlenstiel-Grunow; Kerstin Benz; Marcus R Benz; Klemens Budde; Anja K Büscher; Thomas Fehr; Markus Feldkötter; Norbert Graf; Britta Höcker; Therese Jungraithmayr; Günter Klaus; Birgit Koehler; Martin Konrad; Birgitta Kranz; Carmen R Montoya; Dominik Müller; Thomas J Neuhaus; Jun Oh; Lars Pape; Martin Pohl; Brigitte Royer-Pokora; Uwe Querfeld; Reinhard Schneppenheim; Hagen Staude; Giuseppina Spartà; Kirsten Timmermann; Frauke Wilkening; Simone Wygoda; Carsten Bergmann; Markus J Kemper
Journal:  Clin J Am Soc Nephrol       Date:  2015-03-27       Impact factor: 8.237

Review 5.  WT1 Alternative Splicing: Role of Its Isoforms in Neuroblastoma.

Authors:  Daniela Maria Rasà; Agata Grazia D'Amico; Grazia Maugeri; Sebastiano Cavallaro; Velia D'Agata
Journal:  J Mol Neurosci       Date:  2017-05-22       Impact factor: 3.444

Review 6.  [Tumor predisposition syndromes and nephroblastoma : Early diagnosis with imaging].

Authors:  N Welter; R Furtwängler; G Schneider; N Graf; J-P Schenk
Journal:  Radiologie (Heidelb)       Date:  2022-08-25

Review 7.  Renal Tumors of Childhood: Radiologic-Pathologic Correlation Part 2. The 2nd Decade: From the Radiologic Pathology Archives.

Authors:  Ellen M Chung; Grant E Lattin; Kimberly E Fagen; Andrew M Kim; Michael A Pavio; Adam J Fehringer; Richard M Conran
Journal:  Radiographics       Date:  2017 Sep-Oct       Impact factor: 5.333

Review 8.  Is Wilms tumor a candidate neoplasia for treatment with WNT/β-catenin pathway modulators?--A report from the renal tumors biology-driven drug development workshop.

Authors:  Daniela Perotti; Peter Hohenstein; Italia Bongarzone; Mariana Maschietto; Mark Weeks; Paolo Radice; Kathy Pritchard-Jones
Journal:  Mol Cancer Ther       Date:  2013-11-20       Impact factor: 6.261

9.  Genomic imbalances pinpoint potential oncogenes and tumor suppressors in Wilms tumors.

Authors:  A C V Krepischi; M Maschietto; E N Ferreira; A G Silva; S S Costa; I W da Cunha; B D F Barros; P E Grundy; C Rosenberg; D M Carraro
Journal:  Mol Cytogenet       Date:  2016-02-24       Impact factor: 2.009

10.  Genetic and epigenetic analyses guided by high resolution whole-genome SNP array reveals a possible role of CHEK2 in Wilms tumour susceptibility.

Authors:  Sara Ciceri; Beatrice Gamba; Paola Corbetta; Patrizia Mondini; Monica Terenziani; Serena Catania; Marilina Nantron; Maurizio Bianchi; Paolo D'Angelo; Federica Torri; Fabio Macciardi; Paola Collini; Martina Di Martino; Fraia Melchionda; Andrea Di Cataldo; Filippo Spreafico; Paolo Radice; Daniela Perotti
Journal:  Oncotarget       Date:  2018-09-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.